Photodynamic therapy for increased delivery of anticancer drugs

Handbook of Photomedicine

Volumn , Issue , 2013, Pages 323-339

  Debefve, Elodie ^a   Wang, Yabo ^b   Krueger, Thorsten ^b   Van Den Bergh, Hubert ^a  

^a EPFL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84962691394     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b15582     Document Type: Chapter

References (68)

1. Alexander, H. R., Jr., and C. C. Butler. 2010. Development of isolated hepatic perfusion via the operative and percutaneous techniques for patients with isolated and unresectable liver metastases. Cancer J 16: 132-141.
2. Bae, Y. H., and K. Park. 2011. Targeted drug delivery to tumors: Myths, reality and possibility. J Control Release 153: 198-205.
3. Bates, D. O., and S. J. Harper. 2002. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 39: 225-237.
4. Bazzoni, G. 2006. Endothelial tight junctions: Permeable barriers of the vessel wall. Thromb Haemost 95: 36-42.
5. Bhuvaneswari, R., Y. Y. Gan, K. K. Yee, K. C. Soo, and M. Olivo. 2007. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma. Int J Mol Med 20: 421-428.
6. Bogatcheva, N. V., S. M. Dudek, J. G. Garcia, and A. D. Verin. 2003. Mitogen-activated protein kinases in endothelial pathophysiology. J Investig Med 51: 341-352.
7. Chen, B., C. Crane, C. He et al. 2008. Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy. Int J Cancer 123: 695-701.
8. Chen, B., B. W. Pogue, I. A. Goodwin et al. 2003. Blood flow dynamics after photodynamic therapy with verteporfin in the RIF-1 tumor. Radiat Res 160: 452-459.
9. Chen, B., B. W. Pogue, P. J. Hoopes, and T. Hasan. 2006a. Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr 16: 279-305.
10. Chen, B., B. W. Pogue, J. M. Luna et al. 2006b. Tumor vascular permeabilization by vascular-targeting photosensitization: Effects, mechanism, and therapeutic implications. Clin Cancer Res 12: 917-923.
11. Cheng, C., E. Debefve, A. Haouala et al. 2010. Photodynamic therapy selectively enhances liposomal doxorubicin uptake in sarcoma tumors to rodent lungs. Lasers Surg Med 42: 391-399.
12. Chojniak, R., L. S. Yu, and R. N. Younes. 2006. Response to chemotherapy in patients with lung metastases: How many nodules should be measured? Cancer Imaging 6: 107-112.
13. Cowled, P. A., L. Mackenzie, and I. J. Forbes. 1987. Pharmacological modulation of photodynamic therapy with hematoporphyrin derivative and light. Cancer Res 47: 971-974.
14. de Vree, W. J., M. C. Essers, H. S. de Bruijn et al. 1996a. Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer Res 56: 2908-2911.
15. de Vree, W. J., A. N. Fontijne-Dorsman, J. F. Koster, and W. Sluiter. 1996b. Photodynamic treatment of human endothelial cells promotes the adherence of neutrophils in vitro. Br J Cancer 73: 1335-1340.
16. Debefve, E., C. Cheng, S. C. Schaefer et al. 2010. Photodynamic therapy induces selective extravasation of macromolecules: Insights using intravital microscopy. J Photochem Photobiol B 98: 69-76.
17. Debefve, E., F. Mithieux, J. Y. Perentes et al. 2011. Leukocyte-endothelial cell interaction is necessary for photodynamic therapy induced vascular permeabilization. Lasers Surg Med 43: 696-704.
18. Debefve, E., B. Pegaz, J. P. Ballini, Y. N. Konan, and H. van den Bergh. 2007. Combination therapy using aspirin-enhanced photodynamic selective drug delivery. Vascul Pharmacol 46: 171-180.
19. Debefve, E., B. Pegaz, H. van den Bergh et al. 2008. Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model. Angiogenesis 11: 235-243.
20. Dejana, E., R. Spagnuolo, and G. Bazzoni. 2001. Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost 86: 308-315.
21. Deli, M. A. 2009. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim Biophys Acta 1788: 892-910.
22. Dreher, M. R., W. Liu, C. R. Michelich et al. 2006. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst 98: 335-344.
23. Dvorak, H. F. 2002. Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20: 4368-4380.
24. Feng, D., J. A. Nagy, J. Hipp, H. F. Dvorak, and A. M. Dvorak. 1996. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 183: 1981-1986.
25. Fingar, V. H. 1996. Vascular effects of photodynamic therapy. J Clin Laser Med Surg 14: 323-328.
26. Fingar, V. H., P. K. Kik, P. S. Haydon et al. 1999. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD). Br J Cancer 79: 1702-1708.
27. Fingar, V. H., T. J. Wieman, and K. W. Doak. 1991. Changes in tumor interstitial pressure induced by photodynamic therapy. Photochem Photobiol 53: 763-768.
28. Fingar, V. H., T. J. Wieman, and P. S. Haydon. 1997. The effects of thrombocytopenia on vessel stasis and macromolecular leakage after photodynamic therapy using photofrin. Photochem Photobiol 66: 513-517.
29. Fingar, V. H., T. J. Wieman, S. A. Wiehle, and P. B. Cerrito. 1992. The role of microvascular damage in photodynamic therapy: The effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res 52: 4914-4921.
30. Foster, T. H., and L. Gao. 1992. Dosimetry in photodynamic therapy: Oxygen and the critical importance of capillary density. Radiat Res 130: 379-383.
31. Foster, T. H., M. C. Primavera, V. J. Marder, R. Hilf, and L. A. Sporn. 1991. Photosensitized release of von Willebrand factor from cultured human endothelial cells. Cancer Res 51: 3261-3266.
32. Fukumura, D., and R. K. Jain. 2007. Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize. J Cell Biochem 101: 937-949.
33. Graff, B. A., I. Bjornaes, and E. K. Rofstad. 2001. Microvascular permeability of human melanoma xenografts to macromolecules: Relationships to tumor volumetric growth rate, tumor angiogenesis, and VEGF expression. Microvasc Res 61: 187-198.
34. Grootenboers, M. J., J. Heeren, B. P. van Putte et al. 2006. Isolated lung perfusion for pulmonary metastases: A review and work in progress. Perfusion 21: 267-276.
35. Han, D., G. M. Beasley, D. S. Tyler, and J. S. Zager. 2011. Minimally invasive intra-arterial regional therapy for metastatic melanoma: Isolated limb infusion and percutaneous hepatic perfusion. Expert Opin Drug Metab Toxicol 7: 1383-1394.
36. He, C., P. Agharkar, and B. Chen. 2008. Intravital microscopic analysis of vascular perfusion and macromolecule extravasation after photodynamic vascular targeting therapy. Pharm Res 25: 1873-1880.
37. Hirschberg, H., F. A. Uzal, D. Chighvinadze et al. 2008. Disruption of the blood-brain barrier following ALA-mediated photodynamic therapy. Lasers Surg Med 40: 535-542.
38. Hobbs, S. K., W. L. Monsky, F. Yuan et al. 1998. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci USA 95: 4607-4612.
39. Jain, R. K. 2005. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 307: 58-62.
40. Jain, R. K., R. T. Tong, and L. L. Munn. 2007. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: Insights from a mathematical model. Cancer Res 67: 2729-2735.
41. Korbelik, M. 2006. PDT-associated host response and its role in the therapy outcome. Lasers Surg Med 38: 500-508.
42. Krammer, B. 2001. Vascular effects of photodynamic therapy. Anticancer Res 21: 4271-4277.
43. Kurohane, K., A. Tominaga, K. Sato et al. 2001. Photodynamic therapy targeted to tumor-induced angiogenic vessels. Cancer Lett 167: 49-56.
44. Lange, N., J. P. Ballini, G. Wagnieres, and H. van den Bergh. 2001. A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV. Invest Ophthalmol Vis Sci 42: 38-46.
45. Lehr, H. A., M. Leunig, M. D. Menger, D. Nolte, and K. Messmer. 1993. Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol 143: 1055-1062.
46. Lentsch, A. B., and P. A. Ward. 2000. Regulation of inflammatory vascular damage. J Pathol 190: 343-348.
47. Leunig, M., A. E. Goetz, F. Gamarra et al. 1994. Photodynamic therapy-induced alterations in interstitial fluid pressure, volume and water content of an amelanotic melanoma in the hamster. Br J Cancer 69: 101-103.
48. Madsen, S. J., and H. Hirschberg. 2010. Site-specific opening of the blood-brain barrier. J Biophotonics 3: 356-367.
49. Maeda, H., J. Wu, T. Sawa, Y. Matsumura, and K. Hori. 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 65: 271-284.
50. Michels, S., and U. Schmidt-Erfurth. 2003. Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci 44: 2147-2154.
51. Narang, A. S., and S. Varia. 2011. Role of tumor vascular architecture in drug delivery. Adv Drug Deliv Rev 63: 640-658.
52. Pegaz, B., E. Debefve, F. Borle et al. 2005. Encapsulation of porphyrins and chlorins in biodegradable nanoparticles: The effect of dye lipophilicity on the extravasation and the photothrombic activity. A comparative study. J Photochem Photobiol B 80: 19-27.
53. Rahman, S., G. Flynn, A. Aitken et al. 2000. Differential recognition of snake venom proteins expressing specific Arg-Gly-Asp (RGD) sequence motifs by wild-type and variant integrin alphaIIbbeta3: Further evidence for distinct sites of RGD ligand recognition exhibiting negative allostery. Biochem J 345, pt. 3: 701-709.
54. Roberts, W. G., and G. E. Palade. 1997. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res 57: 765-772.
55. Schmidt-Erfurth, U. M., G. Richard, A. Augustin et al. 2007. Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol Scand 85: 486-494.
56. Seebach, J., H. J. Madler, B. Wojciak-Stothard, and H. J. Schnittler. 2005. Tyrosine phosphorylation and the small GTPase rac cross-talk in regulation of endothelial barrier function. Thromb Haemost 94: 620-629.
57. Sharman, W. M., C. M. Allen, and J. E. van Lier. 1999. Photodynamic therapeutics: Basic principles and clinical applications. Drug Discov Today 4: 507-517.
58. Sitnik, T. M., J. A. Hampton, and B. W. Henderson. 1998. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: Effects of fluence rate. Br J Cancer 77: 1386-1394.
59. Snyder, J. W., W. R. Greco, D. A. Bellnier, L. Vaughan, and B. W. Henderson. 2003. Photodynamic therapy: A means to enhanced drug delivery to tumors. Cancer Res 63: 8126-8131.
60. Stepinac, T. K., S. R. Chamot, E. Rungger-Brandle et al. 2005. Light-induced retinal vascular damage by Pd-porphyrin luminescent oxygen probes. Invest Ophthalmol Vis Sci 46: 956-966.
61. Thurston, G. 2002. Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J Anat 200: 575-580.
62. van Hinsbergh, V. W., and G. P. van Nieuw Amerongen. 2002. Endothelial hyperpermeability in vascular leakage. Vascul Pharmacol 39: 171-172.
63. van Nieuw Amerongen, G. P., and V. W. van Hinsbergh. 2002. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol 39: 257-272.
64. Vargas, A., M. Zeisser-Labouebe, N. Lange, R. Gurny, and F. Delie. 2007. The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. Adv Drug Deliv Rev 59: 1162-1176.
65. Wang, Y., M. Gonzalez, C. Cheng et al. 2012a. Photodynamic induced uptake of liposomal doxorubicin to rat lung tumors parallels tumor vascular density. Lasers Surg Med 44: 318-324.
66. Wang, Y., J. Y. Perentes, S. C. Schafer et al. 2012b. Photodynamic drug delivery enhancement in tumours does not depend on leukocyte-endothelial interaction in a human mesothelioma xenograft model. Eur J Cardiothorac Surg 42: 348-354.
67. Yuan, F., M. Dellian, D. Fukumura et al. 1995. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res 55: 3752-3756.
68. Yuan, S. Y. 2002. Protein kinase signaling in the modulation of microvascular permeability. Vascul Pharmacol 39: 213-223.